References
1. Dengler R et al. Early treatment of Aspirin and Extended-Release
Dipyridamole versus Aspirin alone for treatment of Minor Ischaemic
Stroke within 24 hour of stroke-onset (EARLY-Trial): a randomised,
open-labelled, blinded-endpoint trial. Eur J Neurol 2009 (Suppl).
2. Diener HC et al. European Stroke Prevention Study 2: Efficacy and
Safety data. J Neurol Sci 1997: 151 (Suppl); 1-77
3. ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone
after cerebral ischaemia of arterial origin (ESPRIT). Lancet 2006:
367; 1665-1673
4. Modified Rankin Scale. Internet Stroke Center. Available at
http://www.strokecenter.org/trials/scale... Accessed
7 September 2009
5. Summary of product characteristics. Asasantin Retard(R). Electronic
medicines compendium. http://emc.medicines.org.uk Accessed
7 September 2009
Contact: John Pugh, Corporate Division Communications, Boehringer Ingelheim GmbH, 55216 Ingelheim/Germany, E-mail: press@boehringer-ingelheim.com
